THIOREDOXIN-INTERACTING PROTEIN: A CRITICAL LINK BETWEEN GLUCOSE TOXICITY AND BETA CELL APOPTOSIS

  1. Junqin Chen, PhD1,
  2. Geetu Saxena, PhD1,
  3. Imran N. Mungrue, PhD2,
  4. Aldons J. Lusis, PhD2 and
  5. Anath Shalev, MD (as7{at}medicine.wisc.edu)1
  1. 1Department of Medicine, University of Wisconsin, Madison, WI 53792
  2. 2Department of Medicine, University of California, Los Angeles, CA 90095

    Abstract

    Objective: In diabetes, glucose-toxicity affects different organ systems including pancreatic islets where it leads to beta cell apoptosis, but the mechanisms are not fully understood. Recently, we identified thioredoxin-interacting protein (TXNIP) as a pro-apoptotic beta cell factor that is induced by glucose raising the possibility that TXNIP may play a role in beta cell glucose-toxicity.

    Resarch Design And Methods: To assess the effects of glucose on TXNIP expression and apoptosis and define the role of TXNIP, we used INS-1 beta cells, primary mouse islets, obese, diabetic BTBR.ob mice and a unique mouse model of TXNIP-deficiency (HcB-19) harboring a natural nonsense mutation in the TXNIP gene.

    Results: Incubation of INS-1 cells at 25mM glucose for 24h led to a 18-fold increase in TXNIP protein as assessed by immunoblotting. This was accompanied by increased apoptosis as demonstrated by a 12-fold induction of cleaved caspase-3. Overexpression of TXNIP revealed that TXNIP induces the intrinsic mitochondrial pathway of apoptosis. Islets of diabetic BTBR.ob mice also demonstrated increased TXNIP and apoptosis as did isolated wild-type islets incubated at high glucose. In contrast, TXNIP-deficient HcB-19 islets were protected against glucose-induced apoptosis as measured by TUNEL and caspase-3, indicating that TXNIP is a required causal link between glucose-toxicity and beta cell death.

    Conclusions: These findings shed new light onto the molecular mechanisms of beta cell glucose-toxicity and apoptosis, demonstrate that TXNIP induction plays a critical role in this vicious cycle and suggest that inhibition of TXNIP may represent a novel approach to reduce glucotoxic beta cell loss.

    Footnotes

      • Received May 25, 2007.
      • Accepted December 23, 2007.